According to Chembio Diagnostics's latest financial reports the company has $18.17 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $18.17 M | -36.82% |
2021-12-31 | $28.77 M | 24.74% |
2020-12-31 | $23.06 M | 26.24% |
2019-12-31 | $18.27 M | 45.88% |
2018-12-31 | $12.52 M | 230.44% |
2017-12-31 | $3.79 M | -64.09% |
2016-12-31 | $10.55 M | 96.29% |
2015-12-31 | $5.37 M | 16.52% |
2014-12-31 | $4.61 M | -52.18% |
2013-12-31 | $9.65 M | 226.92% |
2012-12-31 | $2.95 M | -1.96% |
2011-12-31 | $3.01 M | 40.94% |
2010-12-31 | $2.13 M | 99.99% |
2009-12-31 | $1.06 M | -11.88% |
2008-12-31 | $1.21 M | -57.13% |
2007-12-31 | $2.82 M | -34.1% |
2006-12-31 | $4.29 M | 1748.13% |
2005-12-31 | $0.23 M | 566.38% |
2004-12-31 | $0.03 M | |
2001-09-30 | $0 M | |
2001-03-31 | $0 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Trinity Biotech
TRIB | $6.26 M | -65.56% | ๐ฎ๐ช Ireland |
QuidelOrtho QDEL | $0.16 B | 820.29% | ๐บ๐ธ USA |
OraSure Technologies OSUR | $0.29 B | 1,497.49% | ๐บ๐ธ USA |
Bio-Rad Laboratories BIO | $1.60 B | 8,740.64% | ๐บ๐ธ USA |